Accelerating research in Parkinson’s with GBA
The Silverstein Foundation for Parkinson’s with GBA actively pursues and invests in cutting edge research with the goal of discovering new therapies for the treatment of Parkinson’s Disease in glucocerebrosidase (GBA) mutation carriers.
One Foundation. Several Goals.
The Silverstein Foundation for Parkinson’s with GBA has three main goals:
- To raise awareness around Parkinson’s Disease associated with GBA mutations and relevant clinical trials for mutation carriers;
- To aggressively seek out new, cutting-edge therapeutic approaches to treating and preventing Parkinson’s in GBA mutation carriers;
- To engage with clinicians, academic scientists and biotechnology companies to accelerate research and clinical trials in an effort to rapidly bring new therapeutic options to patients.
We are actively involved in
pre-clinical and clinical programs that could be appropriate for GBA mutation carriers.
In the News
and press releases related
to the Foundation and
Parkinson’s with GBA.